KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

LifeMD (LFMD) Return on Equity (2016 - 2025)

Historic Return on Equity for LifeMD (LFMD) over the last 13 years, with Q3 2025 value amounting to 40.32%.

  • LifeMD's Return on Equity rose 357900.0% to 40.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 40.32%, marking a year-over-year increase of 357900.0%. This contributed to the annual value of 8.2% for FY2024, which is 128400.0% down from last year.
  • According to the latest figures from Q3 2025, LifeMD's Return on Equity is 40.32%, which was up 357900.0% from 14.95% recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Return on Equity peaked at 40.32% during Q3 2025, and registered a low of 92.83% during Q3 2022.
  • Moreover, its 5-year median value for Return on Equity was 1.95% (2023), whereas its average is 1.9%.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -985900bps in 2022, then soared by 946100bps in 2023.
  • Quarter analysis of 5 years shows LifeMD's Return on Equity stood at 30.05% in 2021, then skyrocketed by 122bps to 6.76% in 2022, then tumbled by -40bps to 4.03% in 2023, then tumbled by -163bps to 2.54% in 2024, then soared by 1687bps to 40.32% in 2025.
  • Its Return on Equity was 40.32% in Q3 2025, compared to 14.95% in Q2 2025 and 4.38% in Q1 2025.